Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1517/17460441.2014.897692 | ||||
| Año | 2014 | ||||
| Tipo | revisión |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Expert opinion: There is concern about reproducible data on the use of MSC therapy in rheumatic diseases and specifically SLE. Although most experts consider MSCs to be safe, there are still worries over donor variability, immune-mediated rejection, culture-induced senescence, loss of functional properties and genetic instability or eventual malignant transformation. MSC-released factors could avoid most limiting factors associated with cell therapy and are therefore expected to provide a new and safe therapeutic option at an affordable cost.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | FIGUEROA, F | Hombre |
Universidad de Los Andes, Chile - Chile
|
| 2 | Cuenca Moreno, Jimena | Mujer |
Universidad de Los Andes, Chile - Chile
|
| 3 | La Cava, Antonio | Hombre |
UNIV CALIF LOS ANGELES - Estados Unidos
University of California, Los Angeles - Estados Unidos |